Our services for Biologics research
Our current portfolio for biological drugs comprises peptide mapping, released N-glycan profiling, protein MW and structural characterisation, targeted protein quantification (LC/MS and ELISA), in vivo pharmacokinetic studies and biomolecular interactions.
Structural characterisation is an essential part of the development process of biological drugs. Liquid chromatography - mass spectrometry (LC/MS) based techniques are excellent for this, providing unambiguous structural and quantitative information. Use of state-of-the-art analytical instrumentation and software allows straightforward sample analysis and delivers reliable high-quality results. In addition, enzyme-linked immunosorbent-assays (ELISA) are an efficient and convenient way to quantify proteins, when the needed antibody is available.